Skip to main content

A middle-aged old male with severe mitral regurgitation: Open Heart Surgery and CABG VS No Sugery

This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here after collecting informed patient consent (form downloadable Click Here)  by BMJ Elective Student. 

The patient is a 59-year-old male who had angina-like chest pain during July 2017 characterizing as “chest burn” and “”mild pressure-like sensation” while walking in the morning on his way to the office. His daughter, who is a medical student, thought of taking him to a cardiologist and performed an ECG and chest x-ray which revealed a cardiomegaly. The cardiologist did ECHO on him and told that has mitral valve regurgitation which was of little concern that time and advised a coronary angiogram (CAG). (Past reports are attached) On the next day, he was taken for a CAG which revealed two blocks (single vessel disease; LCX and LMCA normal; LAD- proximally 30% stenosis; RCA- proximally 60-70% stenosis, PLB 70-80% stenosis at mid part) and then without advising PCI prescribed some medications (listed below). He had liver abscess diagnosed in 2006. He also has bronchial asthma, hypertension and diabetes mellitus.

He had been under follow-up for a while until recently he is taken to an interventional cardiologist for a follow-up. He does not feel chest discomfort at rest, however, gets occasional chest discomfort which is only during walking (mostly in the morning) for some distance (5-10 minutes). This time doctor did another ECHO and ECG found severe mitral regurgitation (grade IV) and advised CABG and MVR (current reports are attached) and prescribed new medications (listed below).


Medications list from 2017:
  1. Losartan Potassium + Hydrochlorothiazide (Once daily after lunch)
  2. Doxofylline 200 mg (once daily)
  3. Trimetazidine mg (twice daily)
  4. Pantoprazole 40 mg (twice daily)
  5. Losartan potassium 50 mg (once at night)
  6. Salmeterol and fluticasone (25/250)
  7. Salbutamol (as needed)


Medications list recently prescribed in 2018 (December 1st):
  1. Aspirin 75 mg (once at night)
  2. Nitrates (twice daily)
  3. Furosemide 40 (once in the morning)
  4. Telmisartan 40 (once at night)
  5. Atorvastatin 20 (once at night)


2017 reports:
  • Chest x-ray: cardiomegaly and enlarged both hiler shadows
  • CAG (attached)
  • ECHO report (attached)
2018 reports:
  • ECHO report (attached)
  • New prescription (attached)

Recent prescription from an interventional cardiologist 


ECHO report part 1 performed in December 2018
                                      ECHO report part 2 performed in December 2018


Schematic of the CAG performed in 2017

Old ECHO (part 1) performed in 2017 showing grade III MR


Old ECHO (part 2) performed in 2017 showing grade III MR



Comments

Popular posts from this blog

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

drugs to avoid or use in terms of their pregnancy category

The optimal AEDs therapy of women with epilepsy who are of childbearing age is unclear because of a lack of conclusive data on the comparative teratogenicity of different antiseizure drugs and no antiepileptic drug has proven safe in pregnancy in terms of teratogenesis. Data on the comparative efficacy of various antiseizure drugs for controlling seizures during pregnancy are also quite limited, and there are no randomized trials in this setting. Treatment must be individualized for all patients. Women with epilepsy are classified as high risk during pregnancy and as there are no clear data indicating that any drug is without risk in pregnancy therefore, the antiseizure drug regimen should be optimized six months prior to planned conception.  Choice of antiepileptic drugs in women of childbearing age and  pregnant women with epilepsy:  1. T he antiseizure drug that stops seizures in a given patient is the one that should be used with an exception of valproate. 2.